JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB140363

Cell Cycle In-Cell ELISA Kit (Fluorescent)

Be the first to review this product! Submit a review

|

(5 Publications)

Cell Cycle In-Cell ELISA Kit (Fluorescent) is a Cell-based (quantitative) ELISA for the measurement of Cell Cycle In-Cell (Fluorescent) in Human, Mouse in Cell Samples samples.

View Alternative Names

CDKN2, CDK2, Cyclin-dependent kinase 2, Cell division protein kinase 2, p33 protein kinase

3 Images
In-Cell ELISA - Cell Cycle In-Cell ELISA Kit (Fluorescent) (AB140363)
  • In-Cell ELISA

Supplier Data

In-Cell ELISA - Cell Cycle In-Cell ELISA Kit (Fluorescent) (AB140363)

HeLa cells treated with a titration of Hydroxyurea.

Data shown is for 24 hour treatment with 1.6 – 5000 nM hydroxyurea. Cdk2 pTyr15 intensity increases with hydroxyurea treatment dose whereas Histone H3 pSer10 intensity decreases.

In-Cell ELISA - Cell Cycle In-Cell ELISA Kit (Fluorescent) (AB140363)
  • In-Cell ELISA

Supplier Data

In-Cell ELISA - Cell Cycle In-Cell ELISA Kit (Fluorescent) (AB140363)

Sample experiment using ab140363 on HeLa cells treated with Paclitaxel and Hydroxyurea. Data shown is for 24 hour treatment with 1 mM hydroxyurea, 333 nM paclitaxel and untreated (Control). (Normalized intensity is described in section 9.)

Western blot - Cell Cycle In-Cell ELISA Kit (Fluorescent) (AB140363)
  • WB

Supplier Data

Western blot - Cell Cycle In-Cell ELISA Kit (Fluorescent) (AB140363)

Antibody specificity demonstrated by Western Blot Analysis. Whole cell lysates from HeLa cells were analyzed by Western blot with the primary antibodies used in this assay kit.
(A) Histone H3 pSer10 antibody :
Lane 1 -Untreated,
Lane 2- hydroxyurea = G1/S arrest,
Lane 3- paclitaxel = G2/M arrest .
(B) Cdk2 pTyr15 antibody :
Lane 1 -Untreated,
Lane 2-, thymidine = G1/S arrest,
Lane 3- nocodazole = G2/M arrest.

false

Key facts

Detection method

Fluorescent

Sample types

Adherent cells

Reacts with

Mouse, Human

Assay type

Cell-based (quantitative)

Assay time

6h 30m

Assay Platform

Microplate

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

ab140363 is an In-Cell ELISA (ICE) assay kit that uses quantitative immunocytochemistry to measure levels of Cdk2 protein phosphorylated Tyr15 and Histone H3 protein phosphorylated Ser10 levels in cultured cells. Cells are fixed in a microplate and targets of interest are detected with highly specific, well-characterized antibodies. Relative target levels are quantified using secondary antibodies conjugated to either horseradish peroxidase (HRP) or alkaline phosphatase (AP) which generate signal through the use of two spectrally distinct fluorogenic substrates. Fluorescence is measured using a standard fluorescent spectrophotometer and relative levels of target proteins are quantified. Optionally, antibody signal intensity can be normalized to the total cell amount using Janus Green stain. In-Cell ELISA (ICE) technique generates quantitative data with specificity similar to Western blotting, but with much greater quantitative precision and higher throughput due to the greater dynamic range and linearity of fluorescence detection and the ability to run up to 96 samples in parallel. This method rapidly fixes the cells in situ, stabilizing the in vivo levels of proteins and their post-translational modifications, and thus essentially eliminates changes during sample handling, such as preparation of protein extracts.

Plates are available in our ICE (In-Cell ELISA) Support Pack (ab111542) which can be bought seperately.

The Cdk2 (pTyr15) + Histone H3 (pSer10) In-Cell ELISA Kit (Fluorescent) (ab140363) is designed to study cell cycle effects in response to various stimuli. Monoclonal antibodies specific to Cdk2 (pTyr15) and Histone H3 (pSer10) are used in this high-throughput duplexing plate-based assay. Cdk2 (pTyr15) is elevated in G1/S phase of the cell cycle and Histone H3 (pSer10) is elevated in G2/M phase.
Cyclin-dependent kinase 2 (Cdk2) is a nuclear protein kinase that functions in the G1/S phase of the cell cycle. Inhibitory phosphorylation occurs on residues Thr14 and Tyr15; activation of Cdk2 includes dephosphorylation of these residues by cdc25. Cdk2 can form a complex with Cyclin A, D or E. Phosphorylation of Cdk2 at Tyr15 indicates that a cell is at the G1/S transition.
Histone H3 is one of the four core histone proteins (H2A, H2B, H3 and H4) that pack DNA in nucleosomes. Post-translational modifications of histones include phosphorylation and acetylation and are important for chromatin assembly and gene expression. Phosphorylation of Histone H3 at Ser10 is tightly correlated with chromosome condensation during mitosis. Hence, Histone H3 pSer10 signal indicates a mitotic cell with condensed DNA.
In-Cell ELISA (ICE) technology is used to perform quantitative immunocytochemistry of cultured cells using enzyme linked secondary antibodies and fluorogenic substrates. The technique generates quantitative data with specificity similar to western blotting, but with much greater quantitative precision and higher throughput due to the greater dynamic range and linearity of fluorescence detection and the ability to run up to 96 samples in parallel. Because the Cdk2 (pTyr15) antibody is a rabbit antibody and the Histone H3 (pSer10) antibody is a mouse antibody, they can be measured simultaneously in the same well using the cocktail of provided primary antibodies, species-specific secondary antibodies and fluorogenic substrates. This method rapidly fixes the cells in situ, stabilizing the in vivo levels of proteins and their post-translational modifications, and thus eliminating changes during sample handling, such as in the preparation of protein extracts. Finally, the Cdk2 (pTyr15) and Histone H3 (pSer10) signals can be normalized to cell amount, measured by the provided Janus Green whole cell stain, to further increase the assay precision.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

What's included?

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab140363-1x96Tests", "assetComponentDetails": [ { "size":"1 x 120 µL", "name":"100X Anti-Cdk2 (pTyr15) Primary Antibody", "number":"AB140363-CMP07", "productcode":"" }, { "size":"1 x 20 µL", "name":"1000X Anti-Rabbit IgG/HRP-Labeled Secondary Antibody", "number":"AB140363-CMP06", "productcode":"" }, { "size":"1 x 20 µL", "name":"1000X Anti-Mouse IgG/AP-Labeled Secondary Antibody", "number":"AB140363-CMP05", "productcode":"" }, { "size":"1 x 2 mL", "name":"400X Tween-20", "number":"AB140363-CMP09", "productcode":"" }, { "size":"1 x 50 µL", "name":"8000X Hydrogen Peroxide", "number":"AB140363-CMP10", "productcode":"" }, { "size":"1 x 1.5 mL", "name":"10X Quenching Solution", "number":"AB140363-CMP02", "productcode":"" }, { "size":"1 x 17 mL", "name":"1X Janus Green Stain", "number":"AB140363-CMP13", "productcode":"" }, { "size":"1 x 500 µL", "name":"100X Triton X-100", "number":"AB140363-CMP11", "productcode":"" }, { "size":"1 x 50 µL", "name":"400X Fluorescent Substrate Cocktail", "number":"AB140363-CMP08", "productcode":"" }, { "size":"1 x 100 mL", "name":"10X Phosphate Buffered Saline", "number":"AB140363-CMP01", "productcode":"" }, { "size":"1 x 10 mL", "name":"10X Blocking Solution", "number":"AB140363-CMP12", "productcode":"" }, { "size":"1 x 120 µL", "name":"100X Anti- Histone H3 (pSer10) Primary Antibody", "number":"AB140363-CMP04", "productcode":"" }, { "size":"1 x 12 mL", "name":"Fluorescent Substrate Buffer", "number":"AB140363-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cyclin-dependent kinase 2 (Cdk2) and Histone H3 are critical components in cell cycle regulation. Cdk2 with a mass of approximately 34 kDa is a serine/threonine kinase expressed in various tissues prominently in proliferating cells. It associates with cyclins A and E to regulate progression of the cell cycle from G1 to S phase. Histone H3 a core component of chromatin undergoes post-translational modifications that influence DNA accessibility and transcription. Together Cdk2 and Histone H3 interactions might influence cell cycle and chromatin dynamics.
Biological function summary

Histone H3 is key to chromatin structure and gene regulation. It is part of the nucleosome core which packages DNA into chromatin. Modifications like phosphorylation at serine 10 occur during mitosis and open chromatin structure. Cdk2 influences such modifications via hyperphosphorylated states contributing to DNA replication and repair processes. During these processes Cdk2 forms a complex with cyclins particularly cyclin A to ensure precise control over cell cycle transitions and genomic stability.

Pathways

Cdk2 and Histone H3 connections play roles in cell cycle and DNA damage response pathways. The cell cycle pathway with Cdk2-cyclin E/A involvement promotes G1/S phase transition. In DNA damage response Cdk2 interacts with proteins like p21 to halt cell cycle in response to DNA damage. Histone H3 post-translational changes are regulated within chromatin remodeling pathways affecting gene expression and cell cycle checkpoints integrating with Cdk2's role in the replication machinery.

Aberrations in Cdk2 and Histone H3 functioning link to cancer and neurodevelopmental diseases. Overexpression of Cdk2 can drive unregulated cell proliferation in cancers often associated with reduced function of p21 a Cdk2 inhibitor. Misregulation of Histone H3 phosphorylation correlates with chromatin defects and tumorigenesis. Interventions that target the Cdk2-Histone H3 axis might offer therapeutic potential in these disorders by correcting cycle deregulation and chromatin remodeling abnormalities.

Product protocols

Target data

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis (PubMed : 10499802, PubMed : 10884347, PubMed : 10995386, PubMed : 10995387, PubMed : 11051553, PubMed : 11113184, PubMed : 12944431, PubMed : 15800615, PubMed : 17495531, PubMed : 19966300, PubMed : 20935635, PubMed : 21262353, PubMed : 21596315, PubMed : 28216226, PubMed : 28666995). Phosphorylates CABLES1, CTNNB1, CDK2AP2, ERCC6, NBN, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2 (PubMed : 10499802, PubMed : 10995386, PubMed : 10995387, PubMed : 11051553, PubMed : 11113184, PubMed : 12944431, PubMed : 15800615, PubMed : 19966300, PubMed : 20935635, PubMed : 21262353, PubMed : 21596315, PubMed : 28216226). Triggers duplication of centrosomes and DNA (PubMed : 11051553). Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus (PubMed : 18372919, PubMed : 19238148, PubMed : 19561645). Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in embryonic stem cells (ESCs) (PubMed : 18372919, PubMed : 19238148, PubMed : 19561645). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase (PubMed : 18372919, PubMed : 19238148, PubMed : 19561645). EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing (PubMed : 20935635). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC (PubMed : 19966300). Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis (PubMed : 15800615, PubMed : 20195506, PubMed : 21319273). In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation (PubMed : 15800615). Involved in regulation of telomere repair by mediating phosphorylation of NBN (PubMed : 28216226). Phosphorylation of RB1 disturbs its interaction with E2F1 (PubMed : 10499802). NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication (PubMed : 11051553). Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase (PubMed : 10995386, PubMed : 10995387). Required for vitamin D-mediated growth inhibition by being itself inactivated (PubMed : 20147522). Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner (PubMed : 20079829). USP37 is activated by phosphorylation and thus triggers G1-S transition (PubMed : 21596315). CTNNB1 phosphorylation regulates insulin internalization (PubMed : 21262353). Phosphorylates FOXP3 and negatively regulates its transcriptional activity and protein stability (By similarity). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (PubMed : 29203878).
See full target information CDK2

Additional targets

H3-3A

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Marine drugs 20: PubMed35877720

2022

Pro-Apoptotic Activity of the Marine Sponge Metabolites Pelorol and 5--Ilimaquinone on Human 501Mel Melanoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Carpi,Egeria Scoditti,Beatrice Polini,Simone Brogi,Vincenzo Calderone,Peter Proksch,Sherif S Ebada,Paola Nieri

Frontiers in pharmacology 11:574317 PubMed33071785

2020

miRNA Modulation and Antitumor Activity by the Extra-Virgin Olive Oil Polyphenol Oleacein in Human Melanoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Sara Carpi,Beatrice Polini,Clementina Manera,Maria Digiacomo,Jasmine Esposito Salsano,Marco Macchia,Egeria Scoditti,Paola Nieri

Communications biology 2:381 PubMed31637312

2019

Ribosomal mistranslation leads to silencing of the unfolded protein response and increased mitochondrial biogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Dmitri Shcherbakov,Youjin Teo,Heithem Boukari,Adrian Cortes-Sanchon,Matilde Mantovani,Ivan Osinnii,James Moore,Reda Juskeviciene,Margarita Brilkova,Stefan Duscha,Harshitha Santhosh Kumar,Endre Laczko,Hubert Rehrauer,Eric Westhof,Rashid Akbergenov,Erik C Böttger

Acta obstetricia et gynecologica Scandinavica 98:250-261 PubMed30325501

2018

Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA carriers.

Applications

Unspecified application

Species

Unspecified reactive species

Sakthivignesh Ponandai-Srinivasan,Parameswaran G Lalitkumar,Laura Garcia,Suby Jo Varghese,Joseph W Carlson,Kristina Gemzell-Danielsson,Angelique Floter Radestad

Biochemical and biophysical research communication 450:1345-50 PubMed24997337

2014

Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Kirti Kumar Tiwari,Chun Chu,Xanthi Couroucli,Bhagavatula Moorthy,Krithika Lingappan
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com